Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2021-12-03 00:00:00 ET · period of report 2021-11-01 · accession 0001209191-21-067899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-12-03 | 2021-11-01+ | CPIX | Galante Joseph C | Dir | P - Purchase | $2.65 | +284 | 44.1K | +0.6% | +$752.60 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-01 | P | A | 142 | $2.67 | 43,919 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 2 | Common | Common Stock | 2021-11-02 | P | A | 142 | $2.63 | 44,061 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |